Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related quality of life in patients with severe persistent asthma

Journal of Allergy and Clinical Immunology

Volumn 106, Issue 5, 2000, Pages 852-860

  Fish, James E ^a   Karpel, Jill P ^b   Craig, Timothy J ^c   Bensch, George W ^d   Noonan, Michael ^e   Webb, D Robert ^f   Silverman, Bernard ^g   Schenkel, Eric J ^h   Rooklin, Anthony R ⁱ   Ramsdell, Joe W ^j   Nathan, Robert ^k   Leflein, Jeffrey G ^e   Grossman, Jay ^l   Graft, David F ^m   Gower, Richard G ⁿ   Garay, Stuart M ^o   Frigas, Evangelo ^p   DeGraff, Arthur C ^q   Bronsky, Edwin A ^r   Bernstein, David I ^s   Berger, William ^t   Shneyer, Lucy ^u   Nolop, Keith B ^u   Harrison, Judy E ^u   more..

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

^c PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^d Allergy Immunology and Asthma Medical Group Inc   (United States)

^e Allergy and Asthma Associates ^*

^f Allergy and Asthma Research Associates   (United States)

^g LONG ISLAND COLLEGE HOSPITAL   (United States)

^h Valley Clinical Research Center   (United States)

ⁱ CROZER CHESTER MEDICAL CENTER   (United States)

^j UCSD MEDICAL CENTER   (United States)

^k Asthma and Allergy PC and Research Center   (United States)

^l Allergy Care Consultants Ltd   (United States)

^m PARK NICOLLET CLINIC   (United States)

ⁿ Rockwood Clinic   (United States)

^o New York Gastroenterology Associates   (United States)

^p MAYO CLINIC   (United States)

^q Hartford Lung Physicians Research Center   (United States)

^r Intermountain Clinical Research   (United States)

^s Bernstein Clinical Research Center   (United States)

^t Southern California Research Center   (United States)

^u MERCK RESEARCH LABORATORIES   (United States)

more..

Author keywords

Glucocorticoid; Health related quality of life; Mometasone furoate; Oral corticosteroid dependent asthma; Prednisone; Severe persistent asthma; Steroid sparing

Indexed keywords

BECLOMETASONE DIPROPIONATE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; FLUNISOLIDE; FLUTICASONE PROPIONATE; MOMETASONE FUROATE; NEDOCROMIL; PLACEBO; PREDNISONE; SALMETEROL; THEOPHYLLINE; TRIAMCINOLONE ACETONIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REDUCTION; RESPIRATORY FAILURE; STEROID THERAPY;

EID: 0033678699     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2000.110798     Document Type: Article

References (25)

1. Pharmaceutically-based severity stratification of an asthmatic population
2. Considerations for diagnosing and managing asthma in the elderly
3. Unconventional approaches to drug therapy in severe asthma
4. Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life
5. Oral glucocorticosteroid-sparing effect of budesonide administered by Turbuhaler: A double-blind, placebo-controlled study in adults with moderate-to-severe chronic asthma
6. Fluticasone propionate powder: Oral corticosteroid-sparing effect and improved lung function and quality of life in patients with severe chronic asthma
7. Efficacy and safety of inhaled corticosteroids. New developments
8. Effects of fluticasone propionate, triamcinolone acetonide, prednisone, and placebo on the hypothalamic-pituitary-adrenal axis
9. Effects of budesonide by means of the Turbuhaler on the hypothalamic-pituitary-adrenal axis in asthmatic subjects: A dose-response study
10. Mometasone furoate ointment and cream 0.1 percent in treatment of psoriasis: Comparison with ointment and cream formulations of fluocinolone acetonide 0.025 percent and triamcinolone acetonide 0.1 percent
11. Topical mometasone. A review of its pharmacological properties and therapeutic use in the treatment of dermatological disorders
12. Once daily mometasone furoate aqueous nasal spray is as effective as twice daily beclomethasone dipropionate for treating perennial allergic rhinitis patients
13. A placebo- and active-controlled randomized trial of prophylactic treatment of seasonal allergic rhinitis with mometasone furoate aqueous nasal spray
14. In vitro glucocorticoid receptor binding and transcriptional activation by topically active glucocorticoids
15. The inhibitory effects of topically active glucocorticoids on IL-4, IL-5, and interferon-gamma production by cultured primary CD4+ T cells
16. Glucocorticoids inhibit proliferation and interleukin-4 and interleukin-5 secretion by aeroallergen-specific T-helper type 2 cell lines
17. Once-daily mometasone furoate dry powder inhaler in the treatment of patients with persistent asthma
18. Dose-ranging study of a new steroid for asthma: Mometasone furoate dry powder inhaler
19. Mometasone furoate has minimal effects on the hypothalamic-pituitary-adrenal axis when delivered at high doses
20. Guidelines for the diagnosis and management of asthma
21. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection
22. A scale for the measurement of quality of life in adults with asthma
23. Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma
24. A 12-week dose-ranging study of fluticasone propionate powder in the treatment of asthma
25. Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant